GO
Loading...

Enter multiple symbols separated by commas

Stocks Merck & Co Inc

More

  • Merck: Its Ups And Downs Monday, 21 Apr 2008 | 1:17 PM ET
    Merck

    I usually cover pharma earnings from my desk at CNBC HQ in Englewood Cliffs, NJ. But because Merck made a rare offer to interview its Chairman and CEO Dick Clark exclusively this morning I'm out at Merck's idyllic HQ campus in central NJ.

  • Stocks Close Mixed as Tech, Energy Gain Monday, 21 Apr 2008 | 12:39 PM ET

    Stocks close mixed as quarterly results from Bank of America and National City fueled worries about bank earnings, while energy and tech gained.

  • Playing the Pharma Numbers Monday, 21 Apr 2008 | 10:46 AM ET
    picks_pans_badge.jpg

    Merck's revenues were light, but market reaction was positive.  Eli Lilly's earnings were up sharply, but still disappointed the Street.  So how does an investor play the results?

  • Market Retreats on Uncertainty From Banks Monday, 21 Apr 2008 | 10:27 AM ET

    Stocks started the week lower, hurt by more uncertainty in the banking industry and earnings report that left investors wary after coming off a strong rally last week.

  • Bank Of America Continues Monday Woes Monday, 21 Apr 2008 | 9:37 AM ET

    Monday has not been a great day for bank earnings. Last Monday it was Wachovia that disappointed, today futures dropped at 7 am ET as Bank of America came short of expectations.

  • Merck Shares Gain as Earnings Top Estimates Monday, 21 Apr 2008 | 7:54 AM ET
    merck_logo.jpg

    Merck said first-quarter profit rose on gains from a deal with longtime partner AstraZeneca, although the company's sales rose only 1 percent as negative results of a clinical trial slowed growth of its Vytorin and Zetia cholesterol drugs.

  • Futures Dip, Hurt by National City Cash Plan Monday, 21 Apr 2008 | 7:02 AM ET

    Stock index futures pointed to a lower start for the week as the first wave in a big week of earnings reports left investors wary.

  • Week Ahead: The Big Test Friday, 18 Apr 2008 | 8:09 PM ET
    picks_pans_badge.jpg

    Whenever the stock market rushes full speed ahead, it is hard not to look for the big let-down. That could be the case in the week ahead... Major earnings reports, housing data, annual shareholder meetings, and Tuesday's Pennsylvania presidential primaries are what traders will be watching to see if the trend continues.

  • Dollar's Rebound Tied to Hopes for US Economy Friday, 18 Apr 2008 | 3:55 PM ET
    Exchanging Dollars and Euros

    Signs of renewed confidence in the U.S. financial system could support the dollar next week, provided March's housing reports do not revive chances of a steep interest rate cut.

  • Pfizer Profit Slips, Hurt by Generic Drugs Thursday, 17 Apr 2008 | 9:40 AM ET
    PFIZER.jpg

    Pfizer on Thursday reported a worse-than-expected decline in first-quarter earnings after declining sales of cholesterol fighter Lipitor and medicines now facing generic competition, sending shares down almost 4 percent.

  • Stocks Rally to the End; Intel Powers Techs Wednesday, 16 Apr 2008 | 4:53 PM ET

    Stocks finished at their highs for the day Wednesday as investors cheered the latest round of earnings, which included Intel and JPMorgan.

  • Stocks Rebound After 'Beige' Mood Swing Wednesday, 16 Apr 2008 | 3:08 PM ET

    Stocks rose sharply Wednesday as investors cheered the latest round of earnings, which included Intel and JPMorgan Chase.

  • Merck Misrepresented Vioxx Data: JAMA Report Tuesday, 15 Apr 2008 | 3:47 PM ET

    A new report in the Journal of the American Medical Association is highly critical of drugmaker Merck and its handling of the painkiller Vioxx.

  • AstraZeneca Shares Leap on Nexium Settlement Deal Tuesday, 15 Apr 2008 | 5:50 AM ET
    astrazeneca_logo1.jpg

    AstraZeneca has settled U.S. patent litigation against India's Ranbaxy Laboratories over its top-selling drug, ulcer pill Nexium, securing future sales and sending its shares soaring.

  • Lightning Round: Motorola, Pfizer, Boeing and More Friday, 11 Apr 2008 | 6:31 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Lightning Round: Yahoo, Petrobras, Ambac and More Thursday, 10 Apr 2008 | 6:35 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • CBOE Volatility Close to Low for the Year Thursday, 10 Apr 2008 | 12:37 PM ET
    080410 VIX.jpg

    With good news from Walmart and Goldman CEO Blankfein saying we are closer to the end of the current financial crisis than the beginning, the markets are rallying. Is Blankfein right or is it the calm before the storm?

  • MannKind Being Its Own "Man" About Inhalable Insulin Thursday, 10 Apr 2008 | 12:22 PM ET
    mannkind_logo_1.jpg

    This morning there's a plethora of stuff to blog about: the Takeda-Millennium deal, more commentary about Merck and Schering-Plough and the extent of the Vytorin/Zetia fallout, Genentech's biotech bellweather earnings after the closing bell today, just to name a few.

  • Merck: Cramer's No. 1 Dow Stock Wednesday, 9 Apr 2008 | 7:08 PM ET

    He's expecting a full recovery – and more – for this company.

  • vytorin_logo.jpg

    CNBC and other media outlets have done a significant amount of reporting on cardiologists' reaction to the Vytorin/Zetia study and the effect the ACC panel's opinion might have on the heart doctors' prescription writing.